136 related articles for article (PubMed ID: 38266937)
1. Therapeutic effect of 5-ASA and hesperidin-loaded chitosan/Eudragit® S100 nanoparticles as a pH-sensitive carrier for local targeted drug delivery in a rat model of ulcerative colitis.
Abdollahy A; Salehi M; Mahami S; Bernkop-Schnürch A; Vahedi H; Gharravi AM; Mehrabi M
Int J Pharm; 2024 Mar; 652():123838. PubMed ID: 38266937
[TBL] [Abstract][Full Text] [Related]
2. Achillea wilhelmsii-Incorporated Chitosan@Eudragit Nanoparticles Intended for Enhanced Ulcerative Colitis Treatment.
Maleki H; Doostan M; Farzaei MH; Seifi P; Miraghaee S; Doostan M
AAPS PharmSciTech; 2023 Apr; 24(5):112. PubMed ID: 37118443
[TBL] [Abstract][Full Text] [Related]
3. pH-sensitive HPMCP-chitosan nanoparticles containing 5-aminosalicylic acid and berberine for oral colon delivery in a rat model of ulcerative colitis.
Mahami S; Salehi M; Mehrabi M; Vahedi H; Hassani MS; Bitaraf FS; Omri A
Int J Biol Macromol; 2023 Jul; 244():125332. PubMed ID: 37302632
[TBL] [Abstract][Full Text] [Related]
4. Dual Functional Eudragit
Gao C; Yu S; Zhang X; Dang Y; Han DD; Liu X; Han J; Hui M
Int J Nanomedicine; 2021; 16():1405-1422. PubMed ID: 33658780
[TBL] [Abstract][Full Text] [Related]
5. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis.
Wang D; Sun M; Zhang Y; Chen Z; Zang S; Li G; Li G; Clark AR; Huang J; Si L
Phytomedicine; 2020 Nov; 78():153293. PubMed ID: 32777486
[TBL] [Abstract][Full Text] [Related]
6. Taurine loaded chitosan-pectin nanoparticle shows curative effect against acetic acid-induced colitis in rats.
Ahmed O; Abdel-Halim M; Farid A; Elamir A
Chem Biol Interact; 2022 Jan; 351():109715. PubMed ID: 34695389
[TBL] [Abstract][Full Text] [Related]
7. Mucus-Penetrating Alginate-Chitosan Nanoparticles Loaded with Berberine Hydrochloride for Oral Delivery to the Inflammation Site of Ulcerative Colitis.
Sun L; Nie X; Lu W; Zhang Q; Fang W; Gao S; Chen S; Hu R
AAPS PharmSciTech; 2022 Jun; 23(6):179. PubMed ID: 35761150
[TBL] [Abstract][Full Text] [Related]
8. Preparing simvastatin nanoparticles by a combination of pH-sensitive and timed-release approaches for the potential treatment of ulcerative colitis.
Fardafshari F; Taymouri S; Minaiyan M; Tavakoli N
J Biomater Appl; 2022 Nov; 37(5):859-871. PubMed ID: 35999010
[TBL] [Abstract][Full Text] [Related]
9. Enteric-coated gelatin nanoparticles mediated oral delivery of 5-aminosalicylic acid alleviates severity of DSS-induced ulcerative colitis.
Ahmad A; Ansari MM; Mishra RK; Kumar A; Vyawahare A; Verma RK; Raza SS; Khan R
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 119():111582. PubMed ID: 33321628
[TBL] [Abstract][Full Text] [Related]
10. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of colon adhesive pellets of 5-aminosalicylic acid.
Xu M; Sun M; Qiao H; Ping Q; Elamin ES
Int J Pharm; 2014 Jul; 468(1-2):165-71. PubMed ID: 24746693
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy.
Xiao B; Si X; Zhang M; Merlin D
Colloids Surf B Biointerfaces; 2015 Nov; 135():379-385. PubMed ID: 26275840
[TBL] [Abstract][Full Text] [Related]
13. Designing colon-specific delivery systems for anticancer drug-loaded nanoparticles: an evaluation of alginate carriers.
Ma Y; Coombes AG
J Biomed Mater Res A; 2014 Sep; 102(9):3167-76. PubMed ID: 24124007
[TBL] [Abstract][Full Text] [Related]
14. Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats.
Tozaki H; Odoriba T; Okada N; Fujita T; Terabe A; Suzuki T; Okabe S; Muranishi S; Yamamoto A
J Control Release; 2002 Jul; 82(1):51-61. PubMed ID: 12106976
[TBL] [Abstract][Full Text] [Related]
15. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
Xiao B; Xu Z; Viennois E; Zhang Y; Zhang Z; Zhang M; Han MK; Kang Y; Merlin D
Mol Ther; 2017 Jul; 25(7):1628-1640. PubMed ID: 28143741
[TBL] [Abstract][Full Text] [Related]
16. Fexofenadine-loaded chitosan coated solid lipid nanoparticles (SLNs): A potential oral therapy for ulcerative colitis.
El-Dakroury WA; Zewail MB; Asaad GF; Abdallah HMI; Shabana ME; Said AR; Doghish AS; Azab HA; Amer DH; Hassan AE; Sayed AS; Samra GM; Sallam AM
Eur J Pharm Biopharm; 2024 Mar; 196():114205. PubMed ID: 38311187
[TBL] [Abstract][Full Text] [Related]
17. Oral Delivery of Astaxanthin via Carboxymethyl Chitosan-Modified Nanoparticles for Ulcerative Colitis Treatment.
Zhang W; Zhang X; Lv X; Qu A; Liang W; Wang L; Zhao P; Wu Z
Molecules; 2024 Mar; 29(6):. PubMed ID: 38542929
[TBL] [Abstract][Full Text] [Related]
18. Colitis-targeted hybrid nanoparticles-in-microparticles system for the treatment of ulcerative colitis.
Naeem M; Lee J; Oshi MA; Cao J; Hlaing SP; Im E; Jung Y; Yoo JW
Acta Biomater; 2020 Oct; 116():368-382. PubMed ID: 32937207
[TBL] [Abstract][Full Text] [Related]
19. 5-ASA-loaded SiO2 nanoparticles-a novel drug delivery system targeting therapy on ulcerative colitis in mice.
Tang H; Xiang D; Wang F; Mao J; Tan X; Wang Y
Mol Med Rep; 2017 Mar; 15(3):1117-1122. PubMed ID: 28138699
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis.
Dubey R; Dubey R; Omrey P; Vyas SP; Jain SK
J Drug Target; 2010 Sep; 18(8):589-601. PubMed ID: 20088681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]